current treatments and challenges for patients with egfr exon 20 insertion-positive nsclc
Published 2 years ago • 658 plays • Length 3:58Download video MP4
Download video MP3
Similar videos
-
1:37:00
novel therapies for egfr exon 20 insertions and alk-positive nsclc: developments and implications
-
0:53
treatments for patients with nsclc carrying egfr exon 20 insertions
-
32:15
a visual exploration of new targeted therapies for egfr exon 20 insertions in nsclc
-
1:46
the evolving treatment landscape for nsclc with egfr exon 20 insertion mutations
-
0:52
targeted treatments for egfr exon 20 insertion mutations in nsclc
-
53:55
advancing care for patients with egfr mutation–positive nsclc: precision medicine strategies
-
16:16
managing patients with egfr exon 20 ins in nsclc and egfr tki toxicity
-
4:47
treating non–small cell lung cancer with an egfr exon 20 insertion
-
1:25
current treatment recommendations and future directions for egfr-mutant nsclc
-
9:15
sunvozertinib & egfr exon 20 insertion nsclc-leading developments & current questions in lung cancer
-
2:28
amivantamab in patients with egfr ex20ins-mutated nsclc
-
3:51
wu-kong1: sunvozertinib in nsclc with egfr exon 20 insertion mutations
-
27:17
real world data and diagnostics in patients with nsclc with egfr exon 20 insertions
-
2:07
papillon: amivantamab plus chemotherapy in nsclc with egfr exon 20 insertions
-
27:17
latest in egfr-positive nsclc with exon 20 insertion mutations
-
1:26
the challenge of treatment resistance in patients with advanced egfr-mutated nsclc
-
1:34
pros in papillon trial: amivantamab chemo for egfr exon 20 nsclc
-
1:42
mobocertinib for previously treated nsclc with efgr mutations
-
2:45
activity of egfr tkis in patients with nsclc with uncommon egfr mutations